{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:14:39Z","timestamp":1772500479012,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.biomaterials.2016.01.055","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T18:30:21Z","timestamp":1453919421000},"page":"40-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice"],"prefix":"10.1016","volume":"85","author":[{"given":"Manuela","family":"Donalisio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8828-0905","authenticated-orcid":false,"given":"Paola","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Chiuppesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Pistello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Cagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-105X","authenticated-orcid":false,"given":"Marco","family":"Volante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Bugatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Rusnati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Ranucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ferruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0969-100X","authenticated-orcid":false,"given":"David","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2016.01.055_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/sti.2004.012039","article-title":"A\u00a0systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2","volume":"81","author":"Lookerand","year":"2005","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/505359","article-title":"The cycle of human herpes simplex virus infection: virus transport and immune control","volume":"194","author":"Cunningham","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib3","first-page":"2501","article-title":"Herpes simplex viruses","volume":"vol. 2","author":"Roizman","year":"2007"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States","volume":"296","author":"Xu","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1086\/338231","article-title":"Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis","volume":"185","author":"Wald","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib6","first-page":"47","article-title":"Herpes simplex virus and the chemokines that mediate the inflammation","volume":"303","author":"Carr","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib7","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/513570","article-title":"Herpes simplex virus type 2 and HIV-1: the dialogue between the 2 organisms continues","volume":"195","author":"Corey","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mbs.2013.07.003","article-title":"Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy","volume":"245","author":"Feng","year":"2013","journal-title":"Math. Biosci."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics","volume":"35","author":"Corey","year":"2004","journal-title":"J.\u00a0Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1258\/ijsa.2012.011356","article-title":"Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention","volume":"23","author":"Thurman","year":"2012","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/1756-0500-5-451","article-title":"Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa","volume":"5","author":"Ghebremichael","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib13","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Antiviral therapy of HSV-1 and -2","author":"Kimberlin","year":"2007"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib14","unstructured":"http:\/\/www.who.int\/immunization\/research\/meetings_workshops\/HSV_vaccineRD_Sept2014.pdf."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/M13-2471","article-title":"Daily oral tenofovir and emtricitabinetenofovir preexposure prophylaxis reduces herpes simplex virus type 2acquisition among heterosexual HIV-1-uninfected men and women:a subgroup analysis of a randomized trial","volume":"161","author":"Celum","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pharmthera.2009.05.001","article-title":"Sulfated K5 Escherichia coli polysaccharide derivatives: a novel class of candidate antiviral microbicides","volume":"123","author":"Rusnati","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI32291","article-title":"Microbicide trial screeches to a halt","volume":"117","author":"Honey","year":"2007","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1568005054880127","article-title":"Dendrimers and antivirals: a review","volume":"5","author":"Rosa Borges","year":"2005","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib19","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/AAC.47.12.3784-3788.2003","article-title":"Evaluation of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes","volume":"47","author":"Bernstein","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib20","first-page":"561","article-title":"VivaGel (SPL7013 Gel): a candidate dendrimer\u2013microbicide for the prevention of HIV and HSV infection","volume":"2","author":"Rupp","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib21","doi-asserted-by":"crossref","first-page":"e24095","DOI":"10.1371\/journal.pone.0024095","article-title":"SPL7013 Gel (VivaGel\u00ae) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans","volume":"6","author":"Price","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/pola.26632","article-title":"Poly(amidoamine)s: past, present, and perspectives","volume":"51","author":"Ferruti","year":"2013","journal-title":"J.\u00a0Polym. Sci. A Polym. Chem."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/10611869908996846","article-title":"Poly(amidoamine)s as potential endosomolytic polymers: evaluation in\u00a0vitro and body distribution in normal and tumour-bearing animals","volume":"6","author":"Richardson","year":"1999","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/156856291X00197","article-title":"Poly(amidoamine)s with potential as drug carriers: degradation and cellular toxicity","volume":"2","author":"Ranucci","year":"1991","journal-title":"J.\u00a0Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/bm060054m","article-title":"Synthesis, physicochemical properties, and preliminary biological characterizations of a novel amphoteric agmatine-based poly(amidoamine) with RGD-like repeating units","volume":"7","author":"Franchini","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib26","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1021\/bm061126c","article-title":"Prevailingly cationic agmatine-based amphoteric polyamidoamine as a nontoxic, nonhemolytic, and \u201cstealthlike\u201d DNA complexing agent and transfection promoter","volume":"8","author":"Ferruti","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib27","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1021\/bm100685t","article-title":"Amphoteric agmatine containing polyamidoamines as carriers for plasmid DNA in\u00a0vitro and in\u00a0vivo delivery","volume":"11","author":"Cavalli","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib28","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1128\/AAC.03420-14","article-title":"Agmatine-containing poly(amidoamine)s as novel class of antiviral macromolecules: structural properties and in\u00a0vitro evaluation of infectivity inhibition","volume":"58","author":"Donalisio","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1172\/JCI200113799","article-title":"Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry","volume":"108","author":"Shukla","year":"2001","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1099\/vir.0.18789-0","article-title":"Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor","volume":"84","author":"Bousarghin","year":"2003","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib31","doi-asserted-by":"crossref","first-page":"14525","DOI":"10.1021\/jp304449v","article-title":"Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans","volume":"116","author":"Szewczyk","year":"2012","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.antiviral.2010.01.003","article-title":"Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate","volume":"85","author":"Luganini","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib33","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1128\/AAC.00471-10","article-title":"Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses","volume":"54","author":"Donalisio","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib34","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1128\/AAC.00149-11","article-title":"Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers","volume":"55","author":"Luganini","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib35","doi-asserted-by":"crossref","first-page":"e76482","DOI":"10.1371\/journal.pone.0076482","article-title":"Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures","volume":"8","author":"Bon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib36","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1128\/AAC.00443-15","article-title":"The agmatine-containing poly(amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents the attachment of mucosal human papillomaviruses","volume":"59","author":"Cagno","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00136456","article-title":"Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis","volume":"8","author":"Tognon","year":"1985","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib38","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1128\/JVI.00302-12","article-title":"A\u00a0lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections","volume":"86","author":"Chiuppesi","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0166-3542(90)90004-Q","article-title":"Effect of the estrous cycle on susceptibility of female mice to intravaginal inoculation of herpes simplex virus type 2 (HSV-2)","volume":"14","author":"Teepe","year":"1990","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/10409239509083490","article-title":"Enzymatic degradation of glycosaminoglycans","volume":"30","author":"Ernst","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.febslet.2004.05.033","article-title":"Chemically sulfated Escherichia coli K5 polysaccharide derivatives selectively inhibits HIV-1 Tat biological activities in\u00a0vitro and in\u00a0vivo\u201d","volume":"568","author":"Urbinati","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib42","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/JVI.78.8.4278-4288.2004","article-title":"The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis","volume":"78","author":"Lembo","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib43","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1128\/JVI.80.10.4740-4747.2006","article-title":"Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B","volume":"80","author":"Shogan","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/AAC.05147-11","article-title":"Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection","volume":"56","author":"Spoden","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2005.08.004","article-title":"Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses","volume":"68","author":"Gong","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-391858-1.00001-0","article-title":"Enhanced antiviral activity of acyclovir loaded into nanoparticles","volume":"509","author":"Cavalli","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature04263","article-title":"An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection","volume":"439","author":"Palliser","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-0934(99)00108-1","article-title":"A\u00a0comparison of virus isolation, indirect immunofluorescence and nested multiplex polymerase chain reaction for the diagnosis of primary and recurrent herpes simplex type 1 and type 2 infections","volume":"83","author":"Coyle","year":"1999","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-4899-2444-5_33","article-title":"Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus","volume":"313","author":"Spear","year":"1992","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.antiviral.2004.01.001","article-title":"The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus","volume":"63","author":"Nyberg","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib51","doi-asserted-by":"crossref","first-page":"e25252","DOI":"10.1371\/journal.pone.0025252","article-title":"An important role for syndecan-1 in herpes simplex virus type-1 induced cell-to-cell fusion and virus spread","volume":"6","author":"Karasneh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib52","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1128\/AAC.00771-12","article-title":"Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide","volume":"56","author":"Donalisio","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib53","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.it.2013.08.001","article-title":"Generating protective immunity against genital herpes","volume":"34","author":"Shin","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nm.3103","article-title":"Rapid host immune response and viral dynamics in herpes simplex virus-2 infection","volume":"19","author":"Schiffer","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10529-007-9565-5","article-title":"Hydrophobic polycationic coatings inactivate wild-type and zanamivir- and\/or oseltamivir-resistant human and avian influenza viruses","volume":"30","author":"Haldar","year":"2008","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11095-012-0825-2","article-title":"Decreasing herpes simplex viral infectivity in solution by surface-immobilized and suspended N,N-dodecyl,methyl-polyethylenimine","volume":"30","author":"Larson","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2012.12.027","article-title":"Polyethylenimine combined with liposomes and with decreased numbers of primary amine residues strongly enhanced therapeutic antiviral efficiency against herpes simplex virus type 2 in a mouse model","volume":"66","author":"Maitani","year":"2013","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00705-013-1829-x","article-title":"Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus","volume":"159","author":"Hayashi","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib59","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/mabi.200700102","article-title":"Characterization of the inhibition of enveloped virus infectivity by the cationic acrylate polymer eudragit E100","volume":"7","author":"Alasino","year":"2007","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib60","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/AAC.31.10.1562","article-title":"Inactivation of herpes simplex virus types 1 and 2 by synthetic histidine peptides","volume":"31","author":"Docherty","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib61","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1099\/0022-1317-69-6-1137","article-title":"Interaction of polylysine with the cellular receptor for herpes simplex virus type 1","volume":"69","author":"Langeland","year":"1988","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib62","first-page":"433","article-title":"Solvent-induced virus inactivation by acidic arginine solution","volume":"25","author":"Tsujimoto","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/rmv.546","article-title":"The multipartite system that mediates entry of herpes simplex virus into the cell","volume":"17","author":"Campadelli-Fiume","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib64","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/pro.5560041020","article-title":"Denaturant m values and heat capacity changes: relation to changes in accessible surface areas of protein unfolding","volume":"4","author":"Myers","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib65","doi-asserted-by":"crossref","first-page":"13678","DOI":"10.1128\/JVI.01906-14","article-title":"Crystal structure of herpes simplex virus 2 gD bound to nectin-1 reveals a conserved mode of receptor recognition","volume":"88","author":"Lu","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib66","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1128\/JVI.00725-14","article-title":"Herpes simplex virus type 2 glycoprotein H interacts with integrin \u03b1v\u03b23 to facilitate viral entry and calcium signaling in human genital tract epithelial cells","volume":"88","author":"Cheshenko","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1083\/jcb.117.2.449","article-title":"A\u00a0synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin","volume":"117","author":"Gehlsen","year":"1992","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/JVI.74.1.344-353.2000","article-title":"Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells","volume":"74","author":"Mitola","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1083\/jcb.121.2.461","article-title":"A\u00a0novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin","volume":"121","author":"Vogel","year":"1993","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2010.04.004","article-title":"BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat","volume":"87","author":"Bugatti","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib71","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/infdis\/jiv318","article-title":"Partners in prevention HSV\/HIV transmission study team. Acyclovir prophylaxis reduces the incidence of herpes zoster among HIV-infected individuals: results of a randomized clinical trial","volume":"213","author":"Barnabas","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1742-4690-5-116","article-title":"Topical application of entry inhibitors as \u201cvirustats\u201d to prevent sexual transmission of HIV infection","volume":"5","author":"Lederman","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib73","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/j.1875-9114.1994.tb02850.x","article-title":"Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome","volume":"14","author":"McGrath","year":"1994","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biomaterials.2016.01.055_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/135965350400900117","article-title":"The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases","volume":"9","author":"Heard","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2014.12.005","article-title":"Preclinical assessments of vaginal microbicide candidate safety and efficacy","volume":"92","author":"Fern\u00e1ndez-Romero","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2016.01.055_bib76","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.44.9.2471-2474.2000","article-title":"Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection","volume":"44","author":"Bourne","year":"2000","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:14:48Z","timestamp":1758903288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961216000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":76,"alternative-id":["S0142961216000752"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.01.055","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}